IBDEI2PF ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,43095,0)
;;=90901^^156^2085^3^^^^1
;;^UTILITY(U,$J,358.3,43095,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43095,1,2,0)
;;=2^90901
;;^UTILITY(U,$J,358.3,43095,1,3,0)
;;=3^Biofeedback training any method
;;^UTILITY(U,$J,358.3,43096,0)
;;=97750^^156^2085^6^^^^1
;;^UTILITY(U,$J,358.3,43096,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43096,1,2,0)
;;=2^97750
;;^UTILITY(U,$J,358.3,43096,1,3,0)
;;=3^Extrem Perf Testing,Ea 15min
;;^UTILITY(U,$J,358.3,43097,0)
;;=97161^^156^2085^12^^^^1
;;^UTILITY(U,$J,358.3,43097,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43097,1,2,0)
;;=2^97161
;;^UTILITY(U,$J,358.3,43097,1,3,0)
;;=3^PT Evaluation,Low Complexity
;;^UTILITY(U,$J,358.3,43098,0)
;;=97162^^156^2085^13^^^^1
;;^UTILITY(U,$J,358.3,43098,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43098,1,2,0)
;;=2^97162
;;^UTILITY(U,$J,358.3,43098,1,3,0)
;;=3^PT Evaluation,Moderate Complexity
;;^UTILITY(U,$J,358.3,43099,0)
;;=97163^^156^2085^11^^^^1
;;^UTILITY(U,$J,358.3,43099,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43099,1,2,0)
;;=2^97163
;;^UTILITY(U,$J,358.3,43099,1,3,0)
;;=3^PT Evaluation,High Complexity
;;^UTILITY(U,$J,358.3,43100,0)
;;=97164^^156^2085^14^^^^1
;;^UTILITY(U,$J,358.3,43100,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43100,1,2,0)
;;=2^97164
;;^UTILITY(U,$J,358.3,43100,1,3,0)
;;=3^PT Re-Evaluation
;;^UTILITY(U,$J,358.3,43101,0)
;;=97165^^156^2085^8^^^^1
;;^UTILITY(U,$J,358.3,43101,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43101,1,2,0)
;;=2^97165
;;^UTILITY(U,$J,358.3,43101,1,3,0)
;;=3^OT Evaluation,Low Complexity
;;^UTILITY(U,$J,358.3,43102,0)
;;=97166^^156^2085^9^^^^1
;;^UTILITY(U,$J,358.3,43102,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43102,1,2,0)
;;=2^97166
;;^UTILITY(U,$J,358.3,43102,1,3,0)
;;=3^OT Evaluation,Moderate Complexity
;;^UTILITY(U,$J,358.3,43103,0)
;;=97167^^156^2085^7^^^^1
;;^UTILITY(U,$J,358.3,43103,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43103,1,2,0)
;;=2^97167
;;^UTILITY(U,$J,358.3,43103,1,3,0)
;;=3^OT Evaluation,High Complexity
;;^UTILITY(U,$J,358.3,43104,0)
;;=97168^^156^2085^10^^^^1
;;^UTILITY(U,$J,358.3,43104,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43104,1,2,0)
;;=2^97168
;;^UTILITY(U,$J,358.3,43104,1,3,0)
;;=3^OT Re-Evaluation
;;^UTILITY(U,$J,358.3,43105,0)
;;=96112^^156^2085^4^^^^1
;;^UTILITY(U,$J,358.3,43105,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43105,1,2,0)
;;=2^96112
;;^UTILITY(U,$J,358.3,43105,1,3,0)
;;=3^Developmental Test Admin,1st Hr
;;^UTILITY(U,$J,358.3,43106,0)
;;=96113^^156^2085^5^^^^1
;;^UTILITY(U,$J,358.3,43106,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43106,1,2,0)
;;=2^96113
;;^UTILITY(U,$J,358.3,43106,1,3,0)
;;=3^Developmental Test Admin,Ea Addl 30 min
;;^UTILITY(U,$J,358.3,43107,0)
;;=64479^^156^2086^6^^^^1
;;^UTILITY(U,$J,358.3,43107,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43107,1,2,0)
;;=2^64479
;;^UTILITY(U,$J,358.3,43107,1,3,0)
;;=3^INJ Epidural, foramen, C/T
;;^UTILITY(U,$J,358.3,43108,0)
;;=64480^^156^2086^8^^^^1
;;^UTILITY(U,$J,358.3,43108,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43108,1,2,0)
;;=2^64480
;;^UTILITY(U,$J,358.3,43108,1,3,0)
;;=3^INJ Epidural,C/T Ea Addl Level
;;^UTILITY(U,$J,358.3,43109,0)
;;=64483^^156^2086^7^^^^1
;;^UTILITY(U,$J,358.3,43109,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,43109,1,2,0)
;;=2^64483
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2PF 3763 printed Dec 13, 2024@02:33:15 Page 2
IBDEI2PF ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,43095,0)
+2 ;;=90901^^156^2085^3^^^^1
+3 ;;^UTILITY(U,$J,358.3,43095,1,0)
+4 ;;=^358.31IA^3^2
+5 ;;^UTILITY(U,$J,358.3,43095,1,2,0)
+6 ;;=2^90901
+7 ;;^UTILITY(U,$J,358.3,43095,1,3,0)
+8 ;;=3^Biofeedback training any method
+9 ;;^UTILITY(U,$J,358.3,43096,0)
+10 ;;=97750^^156^2085^6^^^^1
+11 ;;^UTILITY(U,$J,358.3,43096,1,0)
+12 ;;=^358.31IA^3^2
+13 ;;^UTILITY(U,$J,358.3,43096,1,2,0)
+14 ;;=2^97750
+15 ;;^UTILITY(U,$J,358.3,43096,1,3,0)
+16 ;;=3^Extrem Perf Testing,Ea 15min
+17 ;;^UTILITY(U,$J,358.3,43097,0)
+18 ;;=97161^^156^2085^12^^^^1
+19 ;;^UTILITY(U,$J,358.3,43097,1,0)
+20 ;;=^358.31IA^3^2
+21 ;;^UTILITY(U,$J,358.3,43097,1,2,0)
+22 ;;=2^97161
+23 ;;^UTILITY(U,$J,358.3,43097,1,3,0)
+24 ;;=3^PT Evaluation,Low Complexity
+25 ;;^UTILITY(U,$J,358.3,43098,0)
+26 ;;=97162^^156^2085^13^^^^1
+27 ;;^UTILITY(U,$J,358.3,43098,1,0)
+28 ;;=^358.31IA^3^2
+29 ;;^UTILITY(U,$J,358.3,43098,1,2,0)
+30 ;;=2^97162
+31 ;;^UTILITY(U,$J,358.3,43098,1,3,0)
+32 ;;=3^PT Evaluation,Moderate Complexity
+33 ;;^UTILITY(U,$J,358.3,43099,0)
+34 ;;=97163^^156^2085^11^^^^1
+35 ;;^UTILITY(U,$J,358.3,43099,1,0)
+36 ;;=^358.31IA^3^2
+37 ;;^UTILITY(U,$J,358.3,43099,1,2,0)
+38 ;;=2^97163
+39 ;;^UTILITY(U,$J,358.3,43099,1,3,0)
+40 ;;=3^PT Evaluation,High Complexity
+41 ;;^UTILITY(U,$J,358.3,43100,0)
+42 ;;=97164^^156^2085^14^^^^1
+43 ;;^UTILITY(U,$J,358.3,43100,1,0)
+44 ;;=^358.31IA^3^2
+45 ;;^UTILITY(U,$J,358.3,43100,1,2,0)
+46 ;;=2^97164
+47 ;;^UTILITY(U,$J,358.3,43100,1,3,0)
+48 ;;=3^PT Re-Evaluation
+49 ;;^UTILITY(U,$J,358.3,43101,0)
+50 ;;=97165^^156^2085^8^^^^1
+51 ;;^UTILITY(U,$J,358.3,43101,1,0)
+52 ;;=^358.31IA^3^2
+53 ;;^UTILITY(U,$J,358.3,43101,1,2,0)
+54 ;;=2^97165
+55 ;;^UTILITY(U,$J,358.3,43101,1,3,0)
+56 ;;=3^OT Evaluation,Low Complexity
+57 ;;^UTILITY(U,$J,358.3,43102,0)
+58 ;;=97166^^156^2085^9^^^^1
+59 ;;^UTILITY(U,$J,358.3,43102,1,0)
+60 ;;=^358.31IA^3^2
+61 ;;^UTILITY(U,$J,358.3,43102,1,2,0)
+62 ;;=2^97166
+63 ;;^UTILITY(U,$J,358.3,43102,1,3,0)
+64 ;;=3^OT Evaluation,Moderate Complexity
+65 ;;^UTILITY(U,$J,358.3,43103,0)
+66 ;;=97167^^156^2085^7^^^^1
+67 ;;^UTILITY(U,$J,358.3,43103,1,0)
+68 ;;=^358.31IA^3^2
+69 ;;^UTILITY(U,$J,358.3,43103,1,2,0)
+70 ;;=2^97167
+71 ;;^UTILITY(U,$J,358.3,43103,1,3,0)
+72 ;;=3^OT Evaluation,High Complexity
+73 ;;^UTILITY(U,$J,358.3,43104,0)
+74 ;;=97168^^156^2085^10^^^^1
+75 ;;^UTILITY(U,$J,358.3,43104,1,0)
+76 ;;=^358.31IA^3^2
+77 ;;^UTILITY(U,$J,358.3,43104,1,2,0)
+78 ;;=2^97168
+79 ;;^UTILITY(U,$J,358.3,43104,1,3,0)
+80 ;;=3^OT Re-Evaluation
+81 ;;^UTILITY(U,$J,358.3,43105,0)
+82 ;;=96112^^156^2085^4^^^^1
+83 ;;^UTILITY(U,$J,358.3,43105,1,0)
+84 ;;=^358.31IA^3^2
+85 ;;^UTILITY(U,$J,358.3,43105,1,2,0)
+86 ;;=2^96112
+87 ;;^UTILITY(U,$J,358.3,43105,1,3,0)
+88 ;;=3^Developmental Test Admin,1st Hr
+89 ;;^UTILITY(U,$J,358.3,43106,0)
+90 ;;=96113^^156^2085^5^^^^1
+91 ;;^UTILITY(U,$J,358.3,43106,1,0)
+92 ;;=^358.31IA^3^2
+93 ;;^UTILITY(U,$J,358.3,43106,1,2,0)
+94 ;;=2^96113
+95 ;;^UTILITY(U,$J,358.3,43106,1,3,0)
+96 ;;=3^Developmental Test Admin,Ea Addl 30 min
+97 ;;^UTILITY(U,$J,358.3,43107,0)
+98 ;;=64479^^156^2086^6^^^^1
+99 ;;^UTILITY(U,$J,358.3,43107,1,0)
+100 ;;=^358.31IA^3^2
+101 ;;^UTILITY(U,$J,358.3,43107,1,2,0)
+102 ;;=2^64479
+103 ;;^UTILITY(U,$J,358.3,43107,1,3,0)
+104 ;;=3^INJ Epidural, foramen, C/T
+105 ;;^UTILITY(U,$J,358.3,43108,0)
+106 ;;=64480^^156^2086^8^^^^1
+107 ;;^UTILITY(U,$J,358.3,43108,1,0)
+108 ;;=^358.31IA^3^2
+109 ;;^UTILITY(U,$J,358.3,43108,1,2,0)
+110 ;;=2^64480
+111 ;;^UTILITY(U,$J,358.3,43108,1,3,0)
+112 ;;=3^INJ Epidural,C/T Ea Addl Level
+113 ;;^UTILITY(U,$J,358.3,43109,0)
+114 ;;=64483^^156^2086^7^^^^1
+115 ;;^UTILITY(U,$J,358.3,43109,1,0)
+116 ;;=^358.31IA^3^2
+117 ;;^UTILITY(U,$J,358.3,43109,1,2,0)
+118 ;;=2^64483
